NDC codes

466581 NDC codes with hospital pricing data in the network.

• NDC 0409205001 — MAGNESIUM SULFATE 20 GRAM/500 ML (4 %) IN WATER INTRAVENOUS SOLUTION (48 hospitals, 120–1,200 samples)
• NDC 0409412101 — MAGNESIUM SULFATE 4 GRAM/100 ML (4 %) IN WATER INTRAVENOUS PIGGYBACK (43 hospitals, 120–1,200 samples)
• NDC 0409672903 — MAGNESIUM SULFATE 20 GRAM/500 ML (4 %) IN WATER INTRAVENOUS SOLUTION (44 hospitals, 120–1,200 samples)
• NDC 0409672923 — MAGNESIUM SULFATE 4 GRAM/100 ML (4 %) IN WATER INTRAVENOUS PIGGYBACK (68 hospitals, 120–1,200 samples)
• NDC 0409672924 — MAGNESIUM SULFATE 2 GRAM/50 ML (4 %) IN WATER INTRAVENOUS PIGGYBACK (68 hospitals, 120–1,200 samples)
• NDC 2502161281 — MAGNESIUM SULFATE 2 GRAM/50 ML (4 %) IN WATER INTRAVENOUS PIGGYBACK (44 hospitals, 120–1,200 samples)
• NDC 4456742000 — MAGNESIUM SULFATE 2 GRAM/50 ML (4 %) IN WATER INTRAVENOUS PIGGYBACK (51 hospitals, 120–1,200 samples)
• NDC 4456742024 — MAGNESIUM SULFATE 2 GRAM/50 ML (4 %) IN WATER INTRAVENOUS PIGGYBACK (55 hospitals, 120–1,200 samples)
• NDC 4733599202 — MAGNESIUM SULFATE 4 GRAM/100 ML (4 %) IN WATER INTRAVENOUS PIGGYBACK (44 hospitals, 120–1,200 samples)
• NDC 6332310600 — MAGNESIUM SULFATE 4 GRAM/100 ML (4 %) IN WATER INTRAVENOUS PIGGYBACK (66 hospitals, 120–1,200 samples)
• NDC 6332310601 — MAGNESIUM SULFATE 4 GRAM/100 ML (4 %) IN WATER INTRAVENOUS PIGGYBACK (70 hospitals, 120–1,200 samples)
• NDC 6332310605 — MAGNESIUM SULFATE 2 GRAM/50 ML (4 %) IN WATER INTRAVENOUS PIGGYBACK (73 hospitals, 120–1,200 samples)
• NDC 6332310615 — MAGNESIUM SULFATE 20 GRAM/500 ML (4 %) IN WATER INTRAVENOUS SOLUTION (51 hospitals, 120–1,200 samples)
• NDC 80830-2329-03 — TRANEXAMIC ACID 1,000 MG/100 ML(10 MG/ML)IN SOD CHLOR,ISO IV PIGGYBACK (15 hospitals, 1,200 samples)
• NDC 77755-3434-01 — MAGNESIUM SULFATE 40 MG/ML INJ FOR PO (39 hospitals, 1,200 samples)
• NDC CHCO1-8112-68 — MORPHINE PCA 0.2 MG/ML OPIOID TOLERANT - NON WEIGHT BASED (1 hospital, 120–1,200 samples)
• NDC 63323-0265-30 — METHYLPRED NA1GM INJ JWTB (250 hospitals, 515–1,199 samples)
• NDC 63323-0564-97 — ENOXAPARIN SODIUM 40 MG/0.4ML IJ SOSY (109 hospitals, 497–1,199 samples)
• NDC 00536-6412-08 — melatonin 3 mg Tab (15 hospitals, 1,144–1,198 samples)
• NDC 63323058313 — glucagon 1 mg Recon soln 1 Each VIAL (88 hospitals, 253–1,198 samples)
• NDC 00641608025 — ONDANSETRON HCL INJ 4 MG/2ML (2 MG/ML) (78 hospitals, 838–1,198 samples)
• NDC 24208-0910-19 — ERYTHROMYCIN 5 MG/GRAM (0.5 %) OPHT OINT (261 hospitals, 855–1,197 samples)
• NDC 00121176030 — aluminum-magnesium hydroxide 200 mg-200 mg/5 mL oral suspension (75 hospitals, 1,107–1,197 samples)
• NDC 63323089510 — levothyroxine 100 mcg/mL Soln 5 mL VIAL (86 hospitals, 1,107–1,197 samples)
• NDC 00338109904 — AMINO ACID 5 % NO.6 IN DEXTROSE 15 % INTRAVENOUS SOLUTION (116 hospitals, 1,107–1,197 samples)
• NDC 00264450005 — PARENTERAL AMINO ACID 15 % COMBINATION NO.6 INTRAVENOUS SOLUTION (69 hospitals, 1,107–1,197 samples)
• NDC 00338109104 — AMINO ACID 4.25 % NO.1 IN DEXTROSE 10 % INTRAVENOUS SOLUTION (59 hospitals, 1,107–1,197 samples)
• NDC 42023020301 — LEVOTHYROXINE 500 MCG INTRAVENOUS POWDER FOR SOLUTION (31 hospitals, 1,107–1,197 samples)
• NDC 00562780501 — RHO (D) IMMUNE GLOBULIN 300MCG (117 hospitals, 431–1,196 samples)
• NDC 50474063698 — SODIUM HYALURONATE 8.5 MG/0.85ML IO SOL PRESYRG (28 hospitals, 1,088–1,196 samples)
• NDC 00074-5647-25 — UNCLASSIFIED DRUGS (4 hospitals, 979–1,195 samples)
• NDC 66993-0730-80 — Dexamethasone Tab 4 mg (54 hospitals, 943–1,195 samples)
• NDC 63323029301 — mepivacaine (PF) 15 mg/mL (1.5 %) Soln 30 mL VIAL (147 hospitals, 545–1,193 samples)
• NDC 72572-0280-10 — ENOXAPARIN 40 MG/0.4 ML SUBCUTANEOUS SYRINGE (12 hospitals, 599–1,193 samples)
• NDC 00703005104 — METHYLPREDNISOLONE ACETATE 80 MG/ML SUSPENSION FOR INJECTION (54 hospitals, 301–1,192 samples)
• NDC 16714008825 — METHYLPREDNISOLONE ACETATE 40 MG/ML SUSPENSION FOR INJECTION (37 hospitals, 301–1,192 samples)
• NDC 25021082105 — METHYLPREDNISOLONE ACETATE 80 MG/ML SUSPENSION FOR INJECTION (28 hospitals, 301–1,192 samples)
• NDC 70860070101 — KETOROLAC TROMETHAMINE INJ 30 MG/ML (91 hospitals, 768–1,191 samples)
• NDC 409490234 — Dextrose Inj 50% (99 hospitals, 929–1,190 samples)
• NDC 00338067104 — KCL 20 MEQ/L (0.15%) IN DEXTROSE 5% & NACL 0.45% INJ (349 hospitals, 182–1,190 samples)
• NDC 61703-0210-11 — METOCLOPRAMIDE 5MG/ML 10M (4 hospitals, 992–1,190 samples)
• NDC 00781353810 — HEPARIN (PORCINE) 1000 UNIT/ML SOLUTION (30 hospitals, 146–1,190 samples)
• NDC 00641600125 — ATIVAN 2 MG/ML IJ SOLN (216 hospitals, 361–1,189 samples)
• NDC 62135043730 — PREDNISOLONE 5 MG TABLET (64 hospitals, 505–1,189 samples)
• NDC 73534050501 — PREDNISOLONE 5 MG TABLET (22 hospitals, 505–1,189 samples)
• NDC 00032-0046-70 — Pancrelipase Cap DR (Creon 6,000) (142 hospitals, 1,071–1,188 samples)
• NDC 00378-1049-01 — DOXEPIN CAP 10 MG (74 hospitals, 1,116–1,188 samples)
• NDC 00264-5705-10 — Heparin Inj 5,000 units/0.5 mL (UD) (16 hospitals, 1,026–1,188 samples)
• NDC 00409012525 — LABETALOL 5 MG/ML INTRAVENOUS SOLUTION (90 hospitals, 162–1,188 samples)
• NDC 00003-7125-11 — NIVOLUMAB-RELATLIMAB-RMBW 240-80 MG/20ML IV SOLN (227 hospitals, 1,052–1,187 samples)